Skip to content

Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis

Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02404636
Acronym
ADDUP
Enrollment
50
Registered
2015-03-31
Start date
2012-01-31
Completion date
2018-01-31
Last updated
2017-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis, Alcoholic

Brief summary

ADDUP is an observational study of patients with alcoholic hepatitis. A structured interview is used to quantitatively estimate: 1. Alcohol use 2. Dietary intake 3. Drug use (legal and illegal) in the weeks preceding onset of acute alcoholic hepatitis. After interview patients are followed up for 12 months with regard to response to therapy and survival. The study is intended to explore potential precipitants of alcoholic hepatitis.

Interventions

OTHERInterview

Brief structured interview

Sponsors

University Hospital Birmingham
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* acute alcoholic hepatitis * aged over 18 years * able to give informed consent

Exclusion criteria

* evidence of other acute or chronic liver disease * episode of alcoholic hepatitis in 6 months before admission * severe hepatic encephalopathy * delirium

Design outcomes

Primary

MeasureTime frameDescription
Changes in alcohol intake, dietary intake or drug use before illness1 monthBehavior before admission (Brief structured interview)

Secondary

MeasureTime frameDescription
Survival after admission (Brief structured interview)12 monthsSurvival
Response to treatment (Brief structured interview)1 weekResponse to treatment (corticosteroids, pentoxifylline or supportive medical care) after 1 week, measured by Lille score

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026